Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Solid Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04593277
What this trial is testing

Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study

Who this might be right for
Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage II Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Melanoma AJCC v8+13 more
Fred Hutchinson Cancer Center 549
Not applicableStudy completedNCT06409000
What this trial is testing

Evaluation of 3D Surface Scanning for Virtual-CT Based Radiation Therapy Treatment Planning

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Mayo Clinic 26
Not applicableActive Not RecruitingNCT04447222
What this trial is testing

Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors

Who this might be right for
COVID-19 InfectionMalignant Solid Neoplasm
M.D. Anderson Cancer Center 1,242
Testing effectiveness (Phase 2)Active Not RecruitingNCT03599765
What this trial is testing

Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor

Who this might be right for
Oligometastatic Malignant Solid Neoplasm
M.D. Anderson Cancer Center 380
Testing effectiveness (Phase 2)Study completedNCT05538195
What this trial is testing

Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerRectal Cancer+2 more
Chongqing Precision Biotech Co., Ltd 17
Early research (Phase 1)Looking for participantsNCT06912152
What this trial is testing

MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors

Who this might be right for
B7-H3-positive Advanced Malignant Solid Tumors Advanced Primary Peritoneal Tumors or Secondary Abdominal Metastatic Malignant Solid Tumors
Zhejiang University 12
Testing effectiveness (Phase 2)Looking for participantsNCT04165590
What this trial is testing

Plasmodium Immunotherapy for Advanced Malignant Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
CAS Lamvac Biotech Co., Ltd. 60
Early research (Phase 1)Looking for participantsNCT06418061
What this trial is testing

Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
UnresectableLocally Advanced or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd. 198
Not applicableStudy completedNCT01705548
What this trial is testing

Hypofractionated Stereotactic Radiosurgery in Treating Patients With Large Brain Metastasis

Who this might be right for
Metastatic Malignant Neoplasm to BrainUnspecified Adult Solid Tumor, Protocol Specific
Emory University 24
Early research (Phase 1)Active Not RecruitingNCT05311397
What this trial is testing

A166 in Patients With Advanced Solid Malignant Tumors

Who this might be right for
Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 120
Early research (Phase 1)Ended earlyNCT04042480
What this trial is testing

SGN-CD228A in Advanced Solid Tumors

Who this might be right for
Cutaneous MelanomaPleural MesotheliomaHER2 Negative Breast Neoplasms+3 more
Seagen Inc. 88
Early research (Phase 1)Looking for participantsNCT07100210
What this trial is testing

A Clinical Trial Evaluating IL-22BP/LNP Compound in Refractory Malignant Solid Tumors for Safety, Tolerability and Activity

Who this might be right for
Refractory Malignant Solid TumorsmRNA VaccineInterleukin
Xingchen Peng 6
Large-scale testing (Phase 3)WithdrawnNCT05403580
What this trial is testing

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
Mayo Clinic
Early research (Phase 1)Study completedNCT05198089
What this trial is testing

Development of a Digital Tool, MyInspiration, for the Improvement of Spiritual Well-Being in Patients with Cancer

Who this might be right for
Malignant Solid Neoplasm
Ohio State University Comprehensive Cancer Center 52
Not applicableUnknownNCT06512896
What this trial is testing

Clinical Study on Intraluminal Injection of FOLactis

Who this might be right for
Solid TumorImmune ResponsePleural Effusion, Malignant+1 more
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 40
Early research (Phase 1)Study completedNCT06372236
What this trial is testing

UTAA06 Injection for Treatment of Advanced Malignant Solid Tumors

Who this might be right for
Conditions or Focus of Study: B7-H3 Positive Relapsed/Advanced Malignant Solid Tumor
Peking University 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04969887
What this trial is testing

Combination Immunotherapy in Rare Cancers Under InvesTigation

Who this might be right for
Advanced Biliary Tract CancerNeuroendocrine TumorsFemale Reproductive System Neoplasm+1 more
Olivia Newton-John Cancer Research Institute 240
Not applicableStudy completedNCT05766332
What this trial is testing

Evaluating Clinical Evaluation Tools for Predicting Risk of Complications After Hematopoietic Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm
Mayo Clinic 137
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Early research (Phase 1)Active Not RecruitingNCT03212404
What this trial is testing

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Small Cell+10 more
Checkpoint Therapeutics, Inc. 272
Next Page